INVESTMENT UPDATE - CLEAN HYDROGEN TECHNOLOGIES NOW MOVED FROM PROOF OF CONCEPT TO PRODUCTION
Clean Hydrogen Update
Perth, Feb 23, 2024 AEST (ABN Newswire) - Clean Hydrogen Technologies Corp (CHT), a 15.6% and 3.9%, BPH Energy Limited (
ASX:BPH) and Advent Energy Limited investment respectively, has moved from proof of concept to production.
CHT cracks hydrocarbons from natural gas using a process called thermo-catalytic pyrolysis which combines heat, a catalyst and has no oxygen. CHT's feedstock is natural gases hydro-carbons. Importantly there are no CO2 emissions from the core process since the carbon becomes a solid carbon composite product, thus rendering natural gas a clean (no CO2 emissions) source of 2 products, turquoise hydrogen and solid carbon composite.
What is Turquoise Hydrogen?
Turquoise Hydrogen is the industry term used for hydrogen sourced from natural gases hydrocarbons using thermo-catalytic pyrolysis.
What is Carbon Composite?
Since there are no CO2 emissions the carbon becomes solid in the form of a fine black dust type material which in CHT's case is a carbon composite made from CNTs (Carbon Nanotubes) and Alumina (ceramics). Carbon nanotubes have unusual mechanical properties to reinforcement their Alumina composite, acting as a toughening agent. CNTs have a tensile strength greater than steel, conductivity greater than copper and thermal dissipation greater than diamonds. They also resist corrosion and fatigue (ref: https://www.assemblymag.com/articles/93180-can-carbon-nanotubes-replacecopper).
Next Steps for CHT
CHT are next scaling their carbon composite and hydrogen production.
About BPH Energy Limited
BPH Energy Limited (ASX:BPH) is an Australian Securities Exchange listed company developing biomedical research and technologies within Australian Universities and Hospital Institutes.
The company provides early stage funding, project management and commercialisation strategies for a direct collaboration, a spin out company or to secure a license.
BPH provides funding for commercial strategies for proof of concept, research and product development, whilst the institutional partner provides infrastructure and the core scientific expertise.
BPH currently partners with several academic institutions including The Harry Perkins Institute for Medical Research and Swinburne University of Technology (SUT).
| ||
|
